Novel biomarkers derived from the Maintenance of Wakefulness Test as predictors of sleepiness and response to treatment
Open Access
- 2 July 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 47 (12)
Abstract
The Maintenance of Wakefulness Test (MWT) is a widely accepted objective test used to evaluate daytime somnolence and is commonly used in clinical studies evaluating novel therapeutics for excessive daytime sleepiness. In the latter, sleep onset latency (SOL) is typically the sole MWT endpoint. Here, we explored microsleeps, sleep probability measures derived from automated sleep scoring, and quantitative electroencephalography (qEEG) features as additional MWT biomarkers of daytime sleepiness, using data from a phase 1B trial of the selective orexin receptor 2 agonist danavorexton (TAK-925) in people with narcolepsy type 1 (NT1) or type 2 (NT2). Danavorexton treatment reduced the rate and duration of microsleeps during the MWT in NT1 (days 1 and 7; p ≤ 0.005) and microsleep rate in NT2 (days 1 and 7; p < 0.0001). Use of an EEG-sleep-staging−derived measure to determine the probability of wakefulness for each minute revealed a novel metric to track changes in daytime sleepiness, which were consistent with the θ/α ratio, a known biomarker of drowsiness. The slopes of line-fits to both the log-transformed sleepiness score or log-transformed θ/α ratio correlated well to (inverse) MWT SOL for NT1 (R = 0.93 and R = 0.83, respectively) and NT2 (R = 0.97 and R = 0.84, respectively), suggesting that individuals with narcolepsy have increased sleepiness immediately after lights-off. These analyses demonstrate that novel EEG-based biomarkers can augment SOL as predictors of sleepiness and its response to treatment and provide a novel framework for the analysis of wake EEG in hypersomnia disorders.Keywords
Funding Information
- Takeda Pharmaceutical Company
This publication has 44 references indexed in Scilit:
- Assessment of Vigilance and FatigueSleep Medicine Clinics, 2023
- Clinical considerations for the diagnosis of idiopathic hypersomniaSleep Medicine Reviews, 2022
- Maintenance of Wakefulness Test, real and simulated driving in patients with narcolepsy/hypersomniaSleep Medicine, 2019
- Daytime microsleeps during 7 days of sleep restriction followed by 13 days of sleep recovery in healthy young adultsConsciousness and Cognition, 2018
- Characterization of Daytime Sleepiness by Time–Frequency Measures of EEG SignalsJournal of Medical and Biological Engineering, 2015
- Quantitative study of the sleep onset period via detrended fluctuation analysis: Normal vs. narcoleptic subjectsClinical Neurophysiology, 2009
- Health-related quality of life in patients with narcolepsySleep Medicine, 2007
- Health-related quality of life in Italian patients with narcolepsy: the SF-36 health surveySleep Medicine, 2004
- Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humansNeuroscience Letters, 1994
- Maintenance of wakefulness test: A polysomnographic technique for evaluating treatment efficacy in patients with excessive somnolenceElectroencephalography and Clinical Neurophysiology, 1982